Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

61.29
BATS BZX Real-Time Price
As of 12:21pm ET
 +1.17 / +1.95%
Today’s Change
47.97
Today|||52-Week Range
65.46
+16.04%
Year-to-Date
MRK Regular Dividend: MRK will begin trading ex-dividend on 12/13/16 with a $0.47 dividend payable to shareholders of record as of 12/15/16.
The Zacks Analyst Blog Highlights: MasterCard, Merck, Cisco and Visa
Dec 08 / Zacks.com - Paid Partner Content
Kite Pharma Begins Filing for KTE-C19, Presents Data at ASH
Dec 05 / Zacks.com - Paid Partner Content
Top Research Reports for Cisco, Merck & MasterCard
Dec 07 / Zacks.com - Paid Partner Content
Merck's Keytruda Gets Priority Review for Hodgkin Lymphoma
Dec 02 / Zacks.com - Paid Partner Content
Why AstraZeneca plc Stock Slumped in November
Dec 07 / MotleyFool.com - Paid Partner Content
Pharma Stock Roundup: Nivalis Falls on Study Data, Priority Reviews for Merck's Keytr...
Dec 02 / Zacks.com - Paid Partner Content
Lilly: Jardiance Label to Add Cardiovascular Indication
Dec 06 / Zacks.com - Paid Partner Content
Alexandria Real Estate, Merck Ink Long-Term Pharma Lease
Dec 01 / Zacks.com - Paid Partner Content
Intermediate Trade: Merck
Dec 06 / TheStreet.com - Paid Partner Content
5 Top Performing S&P 500 Stocks of November
Dec 01 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close60.12
Today’s open60.49
Day’s range60.45 - 61.43
Volume273,139
Average volume (3 months)10,830,340
Market cap$165.8B
Dividend yield3.07%
Data as of 12:21pm ET, 12/09/2016

Growth & Valuation

Earnings growth (last year)-61.67%
Earnings growth (this year)+5.11%
Earnings growth (next 5 years)+6.00%
Revenue growth (last year)-7.92%
P/E ratio31.3
Price/Sales3.87
Price/Book3.74

Competitors

 Today’s
change
Today’s
% change
NVSNovartis+2.12+3.14%
PFEPfizer+0.79+2.55%
SNYSanofi+0.45+1.13%
ABBVAbbVie+0.73+1.20%
Data as of 12:21pm ET, 12/09/2016

Financials

Next reporting dateFebruary 8, 2017
EPS forecast (this quarter)$0.89
Annual revenue (last year)$38.8B
Annual profit (last year)$4.4B
Net profit margin11.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
Kenneth C. Frazier
Chief Financial Officer &
Executive Vice President
Robert M. Davis
Corporate headquarters
Kenilworth, New Jersey

Forecasts


Search for Jobs